Skystar Bio-pharmaceutical Co. (fka SKBI)

[RealDutch]

so are you saying that failure to file the 2014 10k, failure to file the 2015 Q1 10Q, failure to file the 2015 Q2 10Q, providing fraudulent bank statements to the auditor, $24 million in A/R that were never collected and failure to find $16 million in cash are minor?

Look, I was the one who said that SKBI was overvalued when people were willing to pay $6 or $8 for the stock. The company was having problems with getting licenses and account receivables back then. It was all in the SEC filings. Perhaps I didn't talk about it on this message board, but elsewhere. So there is nothing you can teach me. Besides, it's too late now, isn't it. You should have pointed it out 6 months ago.